TIDMMYX TIDMTTM
RNS Number : 3352V
MyCelx Technologies Corporation
13 April 2021
13 April 2021
MYCELX Technologies Corporation
("MYCELX" or the "Company") (AIM: MYX)
Grant of Options
The Company announces the grant of share options over the
Company's common shares of US$0.025 each ("Common Shares") under
the 2011 MYCELX Omnibus Performance Incentive Plan which was
extended at the 2019 Annual Meeting (the "Plan").
Details of the awards to Directors and a PDMR on 12 April 2021
together with their current beneficial holding of Common Shares are
presented in the following below:
Grant of Share Options to Chief Financial Officer
Name Number of share Exercise Total number Total number of
options granted price of share options share options
held following as % of current
this notification issued share capital
Kimberly Slayton 140,000 US$ 0.69* 270,000 1.39%
Ms. Slayton holds no Common Shares in the issued capital of the
Company.
Grant of Share Options to President and Chief Science
Officer
Name Number of share Exercise Total number Total number of
options granted price of share options share options
held following as % of current
this notification issued share capital
Haluk Alper 70,000 US$0.69* 124,339 0.64%
In addition, following this award, Mr. Alper continues to be
interested in 1,262,046 Common Shares, representing 6.49 per cent
of the present issued capital of the Company.
Grant of Share Options to Chief Executive Officer
Name Number of share Exercise Total number Total number of
options granted price of share options share options
held following as % of current
this notification issued share capital
Connie Mixon 210,000 US$0.69* 413,017 2.12%
In addition, following this award, Connie Mixon continues to be
interested in 2,480,469 Common Shares, representing 12.76 per cent
of the present issued capital of the Company.
The aggregate number of Common Shares held by Ms. Mixon also
includes (a) 150,000 shares held by limited liability companies
controlled by Ms. Mixon; and (b) 202,646 shares held by or on
behalf of Ms. Mixon's children.
The above grants formed part of wider grants of, in aggregate,
769,000 options to employees across the Company, on the same date,
representing 3.95% of the current issued share capital.
These share options granted on 12 April 2021 will vest as to one
third equally on 12 April 2021, 12 April 2022 and 12 April 2023,
and must be exercised prior to the tenth anniversary of the date of
grant, subject to the restrictions on dealing under the Company's
share dealing code.
Following the above grants, a total of 2,038,338 share options
have been granted to directors and employees and are currently
outstanding, representing 10.48% of the issued share capital of
19,443,750 Common Shares.
*Based on the closing mid-market price of the Company's Common
Shares at 12 April 2021, and the closing US/GBP exchange rate at
that date.
For further information please contact:
MYCELX Technologies Corporation
Connie Mixon, CEO Tel: +1 888 306 6843
Kim Slayton, CFO
Canaccord Genuity, Nominated Adviser
Henry Fitzgerald-O'Connor Tel: + 44 20 7523 8000
Georgina McCooke
Celicourt
Mark Antelme Tel: +44 20 8434 2754
Jimmy Lea
The relevant notifications set out below are provided in
accordance with the requirements of Article 19 of the EU Market
Abuse Regulation (No. 596/2014).
Notification of transactions of persons discharging managerial
responsibility or connected persons
1 Details of the person discharging managerial responsibilities
/ person closely associated
a) Name Connie Mixon
-------------------------- ---------------------------------------
2 Reason for the notification
-------------------------------------------------------------------
a) Position/status Director
-------------------------- ---------------------------------------
b) Initial notification Initial notification
/Amendment
-------------------------- ---------------------------------------
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
-------------------------------------------------------------------
a) Name MYCELX Technologies Corporation
-------------------------- ---------------------------------------
b) LEI 213800UJZINIK2VD1G48
-------------------------- ---------------------------------------
4 Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions
have been conducted
-------------------------------------------------------------------
a) Description of the
financial instrument, Common shares of US$0.025
type of instrument
Identification code USU624551078
-------------------------- ---------------------------------------
b) Nature of the transaction Grant of share option to Connie Mixon
under the MYCELX Omnibus Performance
Incentive Plan
-------------------------- ---------------------------------------
c) Price(s) and volume(s) Price(s) Volume(s)
US$0.69 210,000
----------
-------------------------- ---------------------------------------
d) Aggregated information
- Aggregated volume n/a
- Price n/a
-------------------------- ---------------------------------------
e) Date of the transaction 12/04/2021
-------------------------- ---------------------------------------
f) Place of the transaction Grant of the options occurred outside
a trading venue.
-------------------------- ---------------------------------------
1 Details of the person discharging managerial responsibilities
/ person closely associated
a) Name Kimberly Slayton
-------------------------- ---------------------------------------
2 Reason for the notification
-------------------------------------------------------------------
a) Position/status PDMR
-------------------------- ---------------------------------------
b) Initial notification Initial notification
/Amendment
-------------------------- ---------------------------------------
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
-------------------------------------------------------------------
a) Name MYCELX Technologies Corporation
-------------------------- ---------------------------------------
b) LEI 213800UJZINIK2VD1G48
-------------------------- ---------------------------------------
4 Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions
have been conducted
-------------------------------------------------------------------
a) Description of the
financial instrument, Common shares of US$0.025
type of instrument
USU624551078
Identification code
-------------------------- ---------------------------------------
b) Nature of the transaction Grant of share option to Kimberly
Slayton under the MYCELX Omnibus
Performance Incentive Plan
-------------------------- ---------------------------------------
c) Price(s) and volume(s) Price(s) Volume(s)
US$0.69 140,000
----------
-------------------------- ---------------------------------------
d) Aggregated information
- Aggregated volume n/a
- Price n/a
-------------------------- ---------------------------------------
e) Date of the transaction 12/04/2021
-------------------------- ---------------------------------------
f) Place of the transaction Grant of the options occurred outside
a trading venue.
-------------------------- ---------------------------------------
1 Details of the person discharging managerial responsibilities
/ person closely associated
a) Name Haluk Alper
-------------------------- ---------------------------------------
2 Reason for the notification
-------------------------------------------------------------------
a) Position/status Director
-------------------------- ---------------------------------------
b) Initial notification Initial notification
/Amendment
-------------------------- ---------------------------------------
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
-------------------------------------------------------------------
a) Name MYCELX Technologies Corporation
-------------------------- ---------------------------------------
b) LEI 213800UJZINIK2VD1G48
-------------------------- ---------------------------------------
4 Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions
have been conducted
-------------------------------------------------------------------
a) Description of the
financial instrument, Common shares of US$0.025
type of instrument
USU624551078
Identification code
-------------------------- ---------------------------------------
b) Nature of the transaction Grant of share option to Haluk Alper
under the MYCELX Omnibus Performance
Incentive Plan
-------------------------- ---------------------------------------
c) Price(s) and volume(s) Price(s) Volume(s)
US$0.69 70,000
----------
-------------------------- ---------------------------------------
d) Aggregated information
- Aggregated volume n/a
- Price n/a
-------------------------- ---------------------------------------
e) Date of the transaction 12/04/2021
-------------------------- ---------------------------------------
f) Place of the transaction Grant of the options occurred outside
a trading venue.
-------------------------- ---------------------------------------
Notes to Editors
Through its revolutionary oil-free water technology, MYCELX
brings its customers material benefits in terms of performance
enhancement, cost savings and significantly improved environmental
footprints. Working beyond any ordinary filtration methods,
MYCELX's proprietary technology achieves oil removal to less than
one part per million. MYCELX supports leading international
customers across the oil & gas value chain, as well as other
industrial users. MYCELX also provides advanced air filtration
technology for manufacturing and industrial facilities, effectively
removing oil particles and biologicals to maintain continuous and
safe air quality levels.
For more information, visit www.MYCELX.com
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
DSHFLFSFSSIVLIL
(END) Dow Jones Newswires
April 13, 2021 08:49 ET (12:49 GMT)
Mycelx Technologies (LSE:MYX)
Historical Stock Chart
From Jun 2024 to Jul 2024
Mycelx Technologies (LSE:MYX)
Historical Stock Chart
From Jul 2023 to Jul 2024